Prenetics Global Ltd

PRE Nasdaq SEC CIK 1876431
Follow Prenetics Global Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2024 USD · IFRS
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100MFY19FY20FY21FY22FY23FY24
Show the numbers
YearRevenueNet income
FY24$30.6M−$46.3M
FY23$21.7M−$62.7M
FY22$13.2M−$190.5M
FY21$12.5M−$174M
FY20$65.2M−$1.9M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1500%−1000%−500%0%500%FY19FY20FY21FY22FY23FY24
Show the numbers
YearGross marginOperating marginNet margin
FY2450.3%−157.2%−151.2%
FY2340.6%−238.7%−288.5%
FY2227.5%−501.5%−1446.8%
FY2128.7%−452.1%−1388.4%
FY2040.4%−1.5%−3%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0$10MFY19FY20FY21FY22FY23FY24
Show the numbers
YearFree cash flow
FY24−$29.9M
FY23−$14.1M
FY22$9.6M
FY21$4.9M
FY20−$5.7M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Prenetics Global
  • Healthcare median
−1500%−1000%−500%0%FY19FY20FY21FY22FY23FY24
Show the numbers
YearPrenetics GlobalHealthcare median
FY24−151.2%−47%
FY23−288.5%−58%
FY22−1446.8%−80.4%
FY21−1388.4%−71.9%
FY20−3%−62.2%
FY19-−46.3%